// App-Quantinova.ai

3516 : Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).

Researchers

Presenter

  • Jeanne Tie

Principal Investigators

  • Yuxuan Wang

  • Margaret Lee

  • Rachel Wong

  • Suzanne Kosmider

  • Sumitra Ananda

  • Jin Hee Cho

  • Ian Faragher

  • Joseph James McKendrick

  • Carmela Corfield

  • Belinda Lee

  • Kathryn Maree Field

  • Ian Jones

  • Lu Li

  • Cristian Tomasetti

  • Nickolas Papadopoulos

  • Kenneth W. Kinzler

  • Bert Vogelstein

  • Peter Gibbs

Medical Centers

  • Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

  • Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

  • Eastern Health Clinical School, Monash University, Melbourne, Australia

  • Austin Health, Melbourne, Australia

  • Deakin University, Melbourne, Australia

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

  • Royal Melbourne Hospital, Melbourne, Australia

  • Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

  • Division of Biostatistics and Bioinformatics, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved